If these effects occur in adipose tissue during tirzepatide therapy, they could reduce the inflammatory burden that hinders fat loss and metabolic improvement
FDA approves Ozempic (semaglutide) as the only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease [press release]
The lab checklist before starting and when to confirm menopausal status
Note that metoclopramide has MHRA restrictions (maximum 5 days use, risk of extrapyramidal effects) and domperidone has cardiac risk warnings and contraindications
IGF1-LR3, thanks to its long half-life, is highly effective in counteracting myostatin and appears to work by activating a muscle protein called MyoD [1], [2]
For example, inflammation is known to play a role in at least a subset of depressive 238 and psychotic disorders 239